Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV 1) - ANVISA Registration 81062710048

Access comprehensive regulatory information for NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV 1) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81062710048 and manufactured by manufacturer not specified. The registration is held by Cepheid Brasil Importação, Exportação e Comércio de Produtos de Diagnósticos ltda with validity until Aug 08, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including ABBOTT MOLECULAR INC, ALTONA DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
81062710048
2 Related Devices
Registration Details
ANVISA Registration Number: 81062710048
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

Registration Details

81062710048

25351924481202124

18628083000123

Dates and Status

Aug 08, 2022

08/08/2032

09/18/2025 19:00:01

Registration Details

81062710048

25351924481202124

18628083000123

Company Information

CEPHEID AB
Sweden
PT: SUÉCIA

Dates and Status

Aug 08, 2022

08/08/2032

09/18/2025 19:00:01